Better together: assessing the evolving combination therapy picture in I–O

Roisin McGuigan, Editor, Immuno-Oncology Insights, speaks to Yisrael Katz, Senior Medical Director at Viracta Therapeutics, who shares his insights and predictions for the current and future progress of I–O combination therapy.

Please enter your email to access content Read now